3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
7
Gastrointestinal
2
Thoracic
1
Gynecologic
1
CNS
1
Breast
1
Conditions
Lung Neoplasms
11
Carcinoma, Non-Small-Cell Lung
3
Smoking Cessation
2
Disease
2
Colorectal Neoplasms
2
Solitary Pulmonary Nodule
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Pancreatic cancer, adult
1
Ovarian Neoplasms
1
Neoplasms
1
Motor Activity
1
Inflammation
1
Glioblastoma
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
Adenocarcinoma of Lung
1
Interventions
Docetaxel
19
pembrolizumab
14
Surveys and Questionnaires
7
Radiotherapy
7
Paclitaxel
7
Magnetic Resonance Spectroscopy
7
Gemcitabine
7
Standard of Care
6
Specimen Handling
6
Radiosurgery
6
Psychiatric Rehabilitation
6
Early Intervention, Educational
6
Trastuzumab
5
Nivolumab
5
enzalutamide
4
Interviews as Topic
4
motexafin gadolinium
3
cabozantinib
3
X-Rays
3
Sirolimus
3
Methods
3
Educational Status
3
Cisplatin
3
Carboplatin
3
Azacitidine
3
tisotumab vedotin
2
rucaparib
2
pertuzumab
2
pegilodecakin
2
palbociclib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Hematologic Tests
×
Thoracic
×
Clear all
NCT06717295
2026-01-02
CCANED-CIPHER
Dysplasia Diagnostics Limited
Recruiting
6,000 enrolled